Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Relief Therapeutics Holding SA (RLFTF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.45 0.00    0.00%
24/04 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 388
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 1.30 - 1.45
Relief Therapeutics 1.45 0.00 0.00%

RLFTF Recent Sentiments

 
This page contains information on users’ sentiments for the Relief Therapeutics Holding SA stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Jan 11, 2024 Christian Peter Huber   2.23 Feb 02, 2024 @ 1.99 -10.76%
Aug 22, 2023 Aniceto Rodríguez   2.44 Nov 30, 2023 @ 2.28 +6.56%
May 05, 2023 Christian Peter Huber   0.02 Nov 30, 2023 @ 2.28 +11300.00%
Dec 26, 2022 André Bulten   0.03 Jan 02, 2023 @ 0.03 0.00%
Dec 20, 2022 André Bulten   0.03 Dec 26, 2022 @ 0.03 0.00%
Dec 14, 2022 André Bulten   0.03 Dec 19, 2022 @ 0.03 0.00%
Dec 05, 2022 André Bulten   0.03 Dec 12, 2022 @ 0.03 0.00%
Nov 22, 2022 André Bulten   0.03 Nov 28, 2022 @ 0.03 0.00%
Oct 03, 2022 Giancarlo Giovanettin   0.03 Oct 28, 2022 @ 0.03 0.00%
Oct 03, 2022 Liberato Laurini   0.03 Oct 28, 2022 @ 0.03 0.00%
Aug 17, 2022 Liberato Laurini   0.04 Sep 09, 2022 @ 0.03 -25.00%
Jul 25, 2022 laurent truffer   0.03 Aug 19, 2022 @ 0.04 +33.33%
Jul 20, 2022 André Bulten   0.04 Jul 25, 2022 @ 0.03 -25.00%
Jun 27, 2022 laurent truffer   0.03 Jul 22, 2022 @ 0.03 0.00%
Jun 14, 2022 André Bulten   0.03 Jun 20, 2022 @ 0.03 0.00%
Apr 12, 2022 Giu Vel   0.06 May 06, 2022 @ 0.06 0.00%
Mar 18, 2022 Liberato Laurini   0.07 Apr 08, 2022 @ 0.07 0.00%
Mar 15, 2022 Kanthara Muong   0.06 Mar 16, 2022 @ 0.07 -16.67%
Feb 22, 2022 Kanthara Muong   0.07 Feb 28, 2022 @ 0.07 0.00%
Jan 26, 2022 Liberato Laurini   0.07 Feb 18, 2022 @ 0.07 0.00%
Jan 05, 2022 André Bulten   0.10 Jan 10, 2022 @ 0.10 0.00%
Jan 04, 2022 Kanthara Muong   0.08 Jan 07, 2022 @ 0.12 +50.00%
Jan 04, 2022 Tony Haefliger   0.08 Jan 28, 2022 @ 0.08 0.00%
Dec 30, 2021 Claudio Rei   0.07 Jan 21, 2022 @ 0.08 -14.29%
Dec 29, 2021 Morad MEHDI   0.07 Jan 21, 2022 @ 0.08 +14.29%
Dec 20, 2021 Liberato Laurini   0.07 Jan 14, 2022 @ 0.09 +28.57%
Dec 17, 2021 Elio Olivieri   0.07 Dec 20, 2021 @ 0.06 -14.29%
Dec 13, 2021 André Bulten   0.06 Dec 20, 2021 @ 0.06 0.00%
Nov 29, 2021 André Bulten   0.07 Dec 06, 2021 @ 0.07 0.00%
Nov 26, 2021 Michael Michalski   0.06 Nov 29, 2021 @ 0.07 +16.67%
Nov 22, 2021 André Bulten   0.06 Nov 29, 2021 @ 0.07 +16.67%
Nov 18, 2021 Carmelo Sapienza   0.07 Dec 10, 2021 @ 0.07 0.00%
Nov 18, 2021 André Bulten   0.07 Nov 22, 2021 @ 0.06 -14.29%
Nov 12, 2021 André Bulten   0.07 Nov 15, 2021 @ 0.07 0.00%
Nov 11, 2021 Kanthara Muong   0.06 Nov 29, 2021 @ 0.06 0.00%
Nov 05, 2021 Philipp Münzer   0.07 Nov 26, 2021 @ 0.06 +14.29%
Nov 05, 2021 Mišo Matić   0.07 Nov 08, 2021 @ 0.07 0.00%
Nov 04, 2021 Kanthara Muong   0.10 Nov 08, 2021 @ 0.07 -30.00%
Nov 02, 2021 Kanthara Muong   0.08 Nov 03, 2021 @ 0.09 +12.50%
Oct 29, 2021 Mostafa Yusif   0.09 Nov 04, 2021 @ 0.10 -11.11%
Oct 20, 2021 Mostafa Yusif   0.10 Oct 27, 2021 @ 0.09 +10.00%
Oct 14, 2021 ציון זכאי   0.12 Oct 18, 2021 @ 0.10 -16.67%
Oct 13, 2021 Kanthara Muong   0.11 Oct 22, 2021 @ 0.09 -18.18%
Oct 13, 2021 Remo Breitenstein   0.11 Nov 05, 2021 @ 0.07 +36.36%
Oct 12, 2021 Christine Muller   0.12 Nov 05, 2021 @ 0.07 -41.67%
Oct 11, 2021 Fabian Weber   0.10 Nov 05, 2021 @ 0.07 -30.00%
Oct 06, 2021 Liberato Laurini   0.12 Oct 29, 2021 @ 0.09 -25.00%
Oct 06, 2021 Kanthara Muong   0.12 Oct 12, 2021 @ 0.12 0.00%
Oct 04, 2021 Kanthara Muong   0.13 Oct 06, 2021 @ 0.13 0.00%
Sep 27, 2021 Mostafa Yusif   0.16 Oct 12, 2021 @ 0.10 -37.50%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RLFB Comments

Write your thoughts about RELIEF THERAPEUTICS Holding SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Carlos Medina
Carlos Medina Jan 05, 2022 10:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Reason for the spike? Still pump and dump?
Laurent Loboss Badoud
Laurent Loboss Badoud Jan 05, 2022 10:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Relief Therapeutics: Nrx wants to patent its anti-COVID formulation of aviptadil
Marco Singarella
Marco Singarella Jan 05, 2022 10:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Still pump and dump. Is it now a good time to buy?
Mohamed Nedif
Mohamed Nedif Nov 12, 2021 3:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.relieftherapeutics.com/newsblog/relief-reports-that-its-u-s-collaboration-partner-has-announced-it-has-received-a-u-s-food-and-drug-administration-review-of-aviptadil-manufacturing-information
Carlos Medina
Carlos Medina Oct 20, 2021 11:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
With the lawsuit it's pretty much the end for this thing, right?
Marco Singarella
Marco Singarella Oct 20, 2021 11:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Which lawsuit?
Marco Singarella
Marco Singarella Oct 20, 2021 11:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just found this now. Yes sounds the end
Marco Singarella
Marco Singarella Sep 22, 2021 3:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good time to buy now. will definitely go up in the next few weeks
Carlos Medina
Carlos Medina Sep 22, 2021 3:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Based on?
Jaroslav Kovacik
Jaroslav Kovacik Sep 07, 2021 10:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2q 2022 gona bi big
Douglas Boggs
Douglas Boggs Jul 29, 2021 7:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lots of potential but Still no revenue to report
Carlos Medina
Carlos Medina Jul 29, 2021 6:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock is puzzling. No updates, suddenly up 20.30% out of the blue. This week, it's secured more funding, completed acquisitions, Aviptadil gets approval in Georgia plus commercial formulation... and the stock is down about 6-7% .... SMH x-/
Carlos Medina
Carlos Medina Jul 27, 2021 3:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ok this is bigNRx Pharmaceuticals Announces Emergency Use Authorization of ZYESAMI™ (aviptadil) in Nation of Georgia
Jason Conway
Jason Conway Jul 27, 2021 3:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Turns out it wasn’t that big…
Krava Tsakosh
Krava Tsakosh Jun 08, 2021 10:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
That's a nice start of the week
Carlos Medina
Carlos Medina May 21, 2021 12:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock keeps doing this, falls gradually and then it's pumped o and volume another 20% only to fall again due to lack of news and meaningful updates.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email